Compare Charles River Laboratories Intl. Inc (CRL) vs Workday Inc (WDAY) Price & Performance

Charles River Laboratories (CRL) trades at $298.00, down 0.77% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$144.34M for 2025. Analyst consensus is strongly positive with a $305.50 price target, and recent news highlights a strategic growth plan targeting 5%-7% revenue growth by 2030.

The stock's outlook is supported by strong analyst buy ratings and a clear growth strategy, but faces risks from negative profitability metrics and high valuation multiples. Investment opportunity hinges on successful execution of margin expansion and cost savings initiatives, while key risks include persistent net losses and competitive pressures in the healthcare services sector.

Workday (WDAY) trades at $187.81, up 1.93% on the day, with a neutral technical signal and bullish moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $8.45B in 2025, and net income margin improved to 12.32%. Recent news highlights AI product launches and strategic partnerships, alongside a 2.5% headcount reduction aimed at realigning for growth.

WDAY presents a growth opportunity driven by AI integration and expanding market presence, but faces risks from competitive pressures and execution challenges. Analyst consensus is bullish with a $202.92 price target, though valuation multiples remain elevated. Investors should weigh strong fundamentals against potential volatility from market sentiment and operational adjustments.